Stock CCAP CRESCENT CAPITAL BDC, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Crescent Capital BDC, Inc.

Equities

CCAP

US2256551092

Real-time Estimate Cboe BZX
Other stock markets
 03:27:15 2024-06-06 pm EDT 		5-day change 1st Jan Change
18.62 USD +1.39% Intraday chart for Crescent Capital BDC, Inc. +2.31% +6.90%
Jun. 04 Crescent Capital BDC, Inc. Enter Into Seventh Amendment to Loan and Security Agreement CI
May. 23 Keefe, Bruyette & Woods Adjusts Price Target on Crescent Capital BDC to $19 From $18.50, Maintains Outperform Rating MT

Evolution of the average Target Price on Crescent Capital BDC, Inc.

Price target over the last 5 years

History of analyst recommendation changes

613daa826160053f153fb.lKcu3hAHG4E5F89cHOtbR8wUfyVXuTSyRU-xKmUKn9U.ppIdqkBfX8tXLoIvSYodKZheJnQt80fKdyrZeyhgsorNxn-3SHBi2AxTqA~2ece5987febc895dfba3c2a3f266ef3f

Analyst Recommendations on Crescent Capital BDC, Inc.

Keefe, Bruyette & Woods Adjusts Price Target on Crescent Capital BDC to $19 From $18.50, Maintains Outperform Rating MT
Wells Fargo Adjusts Price Target on Crescent Capital BDC to $18 From $16.50, Maintains Equal-Weight Rating MT
Oppenheimer Adjusts Crescent Capital BDC Price Target to $20 From $19, Maintains Outperform Rating MT
Oppenheimer Adjusts Crescent Capital BDC Price Target to $19 From $18, Maintains Outperform Rating MT
Wells Fargo Raises Price Target on Crescent Capital BDC to $16.50 From $16, Maintains Equalweight Rating MT
Wells Fargo Downgrades Crescent Capital BDC to Equal-Weight From Overweight, Trims Price Target to $16 From $16.50 MT
Keefe, Bruyette & Woods Starts Crescent Capital BDC at Outperform With $18 Price Target MT
Oppenheimer Adjusts Crescent Capital BDC Price Target to $18 From $19, Maintains Outperform Rating MT
Raymond James Adjusts Crescent Capital's Price Target to $18 from $20.50, Retains Outperform Rating MT
Oppenheimer Upgrades Crescent Capital BDC to Outperform From Perform, Trims Price Target to $19 From $20 MT
Raymond James Trims Crescent Capital's Price Target to $20.50 From $21, Maintains Outperform Rating MT
Wells Fargo Adjusts Crescent Capital BDC's Price Target to $18.50 from $19.50, Keeps Overweight Rating MT
Wells Fargo Starts Crescent Capital BDC at Overweight With $19.50 Price Target MT
BofA Securities Starts Crescent Capital BDC at Buy With $19.50 Price Target MT
CRESCENT CAPITAL BDC : Oppenheimer Lifts Price Target on Crescent Capital BDC to $20 From $19, Keeps Perform Rating MT
CRESCENT CAPITAL BDC : Oppenheimer Initiates Coverage on Crescent Capital BDC With Perform Rating, $19 Price Target MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
18.36 USD
Average target price
19.2 USD
Spread / Average Target
+4.58%
High Price Target
20 USD
Spread / Highest target
+8.93%
Low Price Target
18 USD
Spread / Lowest Target
-1.96%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Crescent Capital BDC, Inc.

Keefe Bruyette & Woods
Wells Fargo Securities
Oppenheimer
Keefe, Bruyette & Woods
Raymond James
BofA Securities

Ratings for Crescent Capital BDC, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. CCAP Stock
  4. Consensus Crescent Capital BDC, Inc.